Magnolia Officinalis (Magnolia) Bark Extract
Description
Antimicrobial, Skin Conditioning, Antioxidant, Anti-inflammatory
Function
Properties
Regulatory Status
Magnolia Officinalis Bark Extract (CAS 947686-05-7) with active constituents magnolol and honokiol is permitted in the EU under Regulation (EC) 1223/2009 with no concentration limits and permitted in the US with no FDA-specific restrictions. Antioxidant potency is notable, but emerging sensitization case reports warrant careful risk assessment in formulations.
No CIR safety assessment has been published for Magnolia Officinalis Bark Extract, magnolol, or honokiol. Not an OTC monograph ingredient; no GRASE classification applicable. Used in US cosmetics under general FD&C Act cosmetic regulations with no ingredient-specific FDA restrictions. MoCRA standard product listing requirements apply.